logo
episode-header-image
Feb 2024
25m 23s

The Intelligence: If Beijing had a ballo...

The Economist
About this episode

Some within China might prefer another Donald Trump presidency while others might favour Joe Biden. On balance, though: from there, neither option looks great. We look at the steps toward the first drug in four decades to treat the debilitating disease of endometriosis (9:28). And as the word podcasting turns 20 we reflect on a medium close to our hearts (17:51). 


Get a world of insights for 50% off—subscribe to Economist Podcasts+


If you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription. For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.



Hosted on Acast. See acast.com/privacy for more information.

Up next
Today
That warm buzzy feeling: malaria and climate change
As temperatures climb, mosquitoes will migrate to places where natural resistance to malaria is lower. More and more severe natural disasters will make for more breeding grounds. How to stop a deadly disease getting deadlier? In China’s cut-throat food-delivery war, absolutely no ... Show More
24m 43s
Aug 22
Rule and divide: opposition grows in Syria
Less than nine months after Syria’s dictator Bashar al-Assad was toppled, the honeymoon is over. How is the new regime responding to rising dissent? Introducing Britain’s revolutionary retirees: why pensioners increasingly dominate political protest. And celebrating the life of o ... Show More
23m 38s
Aug 21
Stake and chips: will America take 10% of Intel?
Intel was once synonymous with chip-making, but in recent years it has fallen behind. Now the Trump administration may become its biggest shareholder. A political assassination in Colombia raises fears about a return to violence. And what an annual snail race tells us about rural ... Show More
21m 2s
Recommended Episodes
Feb 2024
The Intelligence: If Beijing had a ballot
Some within China might prefer another Donald Trump presidency while others might favour Joe Biden. On balance, though: from there, neither option looks great. We look at the steps toward the first drug in four decades to treat the debilitating disease of endometriosis (9:28). An ... Show More
25m 23s
Jan 2024
The Intelligence: The darkness before the Don
Many of America’s business leaders reckon a second Trump term would be worse for them and for the economy than the first was—not that they’re speaking up about it. We examine just how much of Ukraine’s art and cultural heritage has been moved or looted in the course of the war (9 ... Show More
23m 20s
Dec 2023
The Intelligence: The Economist explains
On our website and in our app, “The Economist explains” is one of the best-read features. Today we invite a few of their authors to keep explaining. What is tranq dope? Why did France get so het up about bedbugs (06:48)? Can superstars’ stadium shows actually affect inflation (11 ... Show More
24m 36s
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s
Jan 2024
The Intelligence: China’s ever grander property crisis
One of the country’s biggest property companies, Evergrande, has been crippled by its debt. What does a new court order mean for prospective homebuyers, and the firm’s creditors? Is there a way for Joe Biden to be replaced by the Democrats’ presidential candidate (09:45)? And the ... Show More
22m 55s
Sep 2023
Money Talks: The price of cheaper medicines
One of the many aims of President Joe Biden’s signature legislation, the Inflation Reduction Act, is to cut the cost of drugs prescribed by Medicare, a government health insurance programme for Americans 65 and over. But the policy could have some side-effects for patients far be ... Show More
44m 53s
Feb 2024
The Intelligence: A former general, elected in Indonesia
Prabowo Subianto stormed to victory in the world’s largest single-day election. But critics say his presidency could jeopardise two decades of democratic progress. Nvidia has dominated the global market for AI accelerator chips for years. Could a company about a third of its size ... Show More
26m 45s
Mar 2024
The Intelligence: Europe is not so hot on its green parties
Melting ski slopes, floods and droughts are enraging the continent’s citizens, but not quite enough for them to consider voting differently. Our correspondent explains what the electorate is weighing up. The world’s largest maker of glasses is branching out into tech (10:41). And ... Show More
24m 14s
Mar 2024
The Intelligence: Russia pushes back on Kharkiv
The northeastern province has been subject to more and more shelling, and Western officials are worried about Ukraine’s capacity to respond. Could there be a breakthrough? Not everyone is happy with the 28-year-old building America’s first nickel-cobalt refinery (08:51). And, som ... Show More
23m 24s
Dec 2023
The Intelligence: The Economist reads
What can A Space Odyssey by Arthur C Clarke tell us about AI? Does Shakespeare's Othello contain a warning for the 2024 US presidential election? Our journalists (and our listeners, too) recommend books that might help us better understand our times. Sign up for a free trial of E ... Show More
35m 41s